|
US4826860A
(en)
*
|
1987-03-16 |
1989-05-02 |
Warner-Lambert Company |
Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
|
|
FR2619713B1
(fr)
*
|
1987-08-25 |
1990-08-31 |
Rhone Poulenc Sante |
Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
|
|
FR2619712B1
(fr)
*
|
1987-08-25 |
1990-08-31 |
Rhone Poulenc Sante |
Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la schizophrenie
|
|
FR2649705B2
(fr)
*
|
1989-07-13 |
1994-09-23 |
Rhone Poulenc Sante |
Medicaments a base de derives de la benzothiazolamine-2, nouveaux derives et leur preparation
|
|
FR2649703B1
(fr)
*
|
1989-07-13 |
1991-11-22 |
Rhone Poulenc Sante |
Derives d'imino-2 polyfluoroalcoxy-6 benzothiazole, leurs procedes de preparation et les medicaments les contenant
|
|
FR2640623B1
(fr)
*
|
1988-12-15 |
1991-03-22 |
Rhone Poulenc Sante |
Derives de la benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
|
FR2649701B2
(fr)
*
|
1988-12-15 |
1991-11-22 |
Rhone Poulenc Sante |
Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
|
ES2043070T3
(es)
*
|
1988-12-15 |
1993-12-16 |
Rhone Poulenc Sante |
Procedimiento para la preparacion de derivados de la benzotiazolamina-2.
|
|
US5236940A
(en)
*
|
1988-12-15 |
1993-08-17 |
Rhone-Poulenc Sante |
Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation
|
|
FR2640622B1
(fr)
*
|
1988-12-15 |
1991-03-22 |
Rhone Poulenc Sante |
Derives de l'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
|
FR2640624B1
(fr)
*
|
1988-12-15 |
1994-08-12 |
Rhone Poulenc Sante |
Medicaments a base de derives de la benzothiazolamine-2, nouveaux derives et leur preparation
|
|
EP0375510B1
(fr)
*
|
1988-12-15 |
1992-11-11 |
Rhone-Poulenc Sante |
Dérivés d'imino-2 polyfluoroalcoxy-6 benzothiazole, leurs procédés de préparation et les médicaments les contenant
|
|
FR2649702B1
(fr)
*
|
1989-07-13 |
1991-11-22 |
Rhone Poulenc Sante |
Derives d'alkylimino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
|
EP0409692B1
(fr)
*
|
1989-07-13 |
1994-03-09 |
Rhone-Poulenc Sante |
Dérivés d'imino-2 hétérocyclylalkyl-3 benzothiazoline, leur préparation et les médicaments les contenant
|
|
FR2661910B1
(fr)
*
|
1990-05-11 |
1992-08-21 |
Rhone Poulenc Sante |
Derives d'imino-2 heterocyclylalkyl-3 benzothiazoline, leur preparation et les medicaments les contenant.
|
|
FR2649704B1
(fr)
*
|
1989-07-13 |
1991-11-22 |
Rhone Poulenc Sante |
Derives d'imino-2 ethyl-3 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
|
|
US5260297A
(en)
*
|
1989-07-13 |
1993-11-09 |
Rhone Poulenc Rorer, S.A. |
2-imino-3-alkylbenzothiazoline derivatives bearing a heterocyclic substituent on the alkyl group, their preparation and medicinal products containing them.
|
|
FR2662160B1
(fr)
*
|
1990-05-18 |
1992-07-24 |
Rhone Poulenc Sante |
Derives d'alkylthio-3 propyl-3 benzothiazoline leur preparation et les medicaments les contenant.
|
|
FR2663030A1
(fr)
*
|
1990-06-05 |
1991-12-13 |
Rhone Poulenc Sante |
Derives selenies de benzothiazoline leur preparation et les medicaments les contenant.
|
|
FR2662695A1
(fr)
*
|
1990-06-05 |
1991-12-06 |
Rhone Poulenc Sante |
Amino-2 polyfluoroalcoxy-6 benzoselenazoles, leur preparation et les medicaments les contenant.
|
|
FR2662694A1
(fr)
*
|
1990-06-05 |
1991-12-06 |
Rhone Poulenc Sante |
Derives du benzoselenazole, leur preparation et les medicaments les contenant.
|
|
FR2663029B1
(fr)
*
|
1990-06-07 |
1992-07-31 |
Rhone Poulenc Sante |
Derives de benzothiazole, leur preparation et les medicaments les contenant.
|
|
FR2688138B1
(fr)
*
|
1992-03-06 |
1995-05-05 |
Rhone Poulenc Rorer Sa |
Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
|
|
FR2699077B1
(fr)
*
|
1992-12-16 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
|
|
FR2700116B1
(fr)
*
|
1993-01-07 |
1995-02-03 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants comme radioprotecteurs.
|
|
FR2700117B1
(fr)
*
|
1993-01-07 |
1995-02-03 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
|
|
FR2702148B1
(fr)
*
|
1993-03-05 |
1995-04-07 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement du neuro-sida.
|
|
FR2726271B1
(fr)
*
|
1994-10-26 |
1996-12-06 |
Rhone Poulenc Rorer Sa |
Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
|
|
FR2786101B1
(fr)
|
1998-11-24 |
2002-07-05 |
Aventis Laboratoire |
Utilisation de la nicergoline dans le traitement de la spasticite
|
|
FR2787028B1
(fr)
|
1998-12-15 |
2002-10-18 |
Aventis Pharma Sa |
Utilisation du riluzole dans le traitement des traumatismes acoustiques
|
|
CA2361924A1
(en)
*
|
1999-01-12 |
2000-07-20 |
Izumi Kamo |
Compositions for treating frequent urination and urinary incontinence
|
|
HRP20030419A2
(en)
|
2000-11-30 |
2004-08-31 |
Pfizer Prod Inc |
Combination of gaba agonists and aldose reductase inhibitors
|
|
IL155704A0
(en)
*
|
2000-11-30 |
2003-11-23 |
Pfizer Prod Inc |
Combination of gaba agonists and sorbitol dehydrogenase inhibitors
|
|
IL163666A0
(en)
|
2002-02-22 |
2005-12-18 |
New River Pharmaceuticals Inc |
Active agent delivery systems and methods for protecting and administering active agents
|
|
EP1633400A2
(en)
*
|
2003-05-16 |
2006-03-15 |
Pfizer Products Inc. |
Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
|
|
WO2005060968A1
(en)
|
2003-12-11 |
2005-07-07 |
Sepracor Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
|
CA2553291A1
(en)
*
|
2004-01-29 |
2005-09-09 |
Pfizer Products Inc. |
Combination of .gamma.-aminobutyric acid modulators and 5-ht1b receptor antagonists
|
|
EP2201963B1
(en)
*
|
2005-04-05 |
2016-01-27 |
Yale University |
Glutamate modulating agents in the treatment of mental disorders
|
|
CA2661448A1
(en)
|
2005-08-25 |
2007-03-01 |
Steven Michael Weiss |
Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
|
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス,インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
|
US7985756B2
(en)
|
2005-10-21 |
2011-07-26 |
Braincells Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
WO2007053596A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
CA2643199A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20100216734A1
(en)
*
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
WO2007134136A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
WO2007134077A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
|
EP2068872A1
(en)
*
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
EP2066355A2
(en)
*
|
2006-09-19 |
2009-06-10 |
Braincells, Inc. |
Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
US20080108827A1
(en)
*
|
2006-10-25 |
2008-05-08 |
Padi Pratap R |
Process for preparing riluzole
|
|
PL2083811T3
(pl)
|
2006-11-22 |
2017-05-31 |
Clinical Research Associates, Llc |
Sposoby leczenia zespołu downa, zespołu łamliwego chromosomu x oraz autyzmu
|
|
US20090167322A1
(en)
*
|
2007-12-28 |
2009-07-02 |
Erik Edmund Magnuson |
Systems and method for classifying a substance
|
|
AU2009231394B2
(en)
*
|
2008-04-03 |
2013-09-05 |
F. Hoffmann-La Roche Ag |
Use of PEGylated IGF-I variants for the treatment of neuromuscular disorders
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
EP2284161A1
(en)
|
2009-07-21 |
2011-02-16 |
Edmond Pharma S.R.L. |
Process for the preparation of riluzole
|
|
HUE046869T2
(hu)
|
2014-11-21 |
2020-04-28 |
Biohaven Therapeutics Ltd |
Riluzol szublingvális formulációja
|
|
BR112017010440A2
(pt)
*
|
2014-11-21 |
2017-12-26 |
Biohaven Pharm Holding Co Ltd |
administração sublingual de riluzol
|
|
KR102279993B1
(ko)
|
2015-09-23 |
2021-07-21 |
엑스더블유파마 리미티드 |
감마-하이드록시부티르산의 전구체 및 이의 조성물 및 용도
|
|
TWI788307B
(zh)
|
2016-10-31 |
2023-01-01 |
美商艾歐凡斯生物治療公司 |
用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞
|
|
JP7664020B2
(ja)
|
2017-01-06 |
2025-04-17 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
カリウムチャネルアゴニストによる腫瘍浸潤リンパ球の増殖及びその治療的使用
|
|
BR112019020464A2
(pt)
|
2017-03-30 |
2020-04-28 |
Xw Laboratories Inc. |
compostos derivados de heteroarila bicíclica, composição farmacêutica compreendendo os ditos compostos, adesivo transdérmico compreendendo a dita composição e uso terapêutico dos compostos e composição
|
|
EP3856719B1
(en)
|
2018-09-30 |
2023-06-07 |
XWPharma Ltd. |
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
|
|
TW202547822A
(zh)
|
2019-12-20 |
2025-12-16 |
香港商凱瑞康寧有限公司 |
4-纈胺醯氧基丁酸的合成方法
|
|
EP4167966A1
(en)
|
2020-06-18 |
2023-04-26 |
XWPharma Ltd. |
Pharmaceutical granulations of water-soluble active pharmaceutical ingredients
|
|
EP4167971A1
(en)
|
2020-06-18 |
2023-04-26 |
XWPharma Ltd. |
Controlled release granulations of water-soluble active pharmaceutical ingredients
|
|
WO2022020621A1
(en)
|
2020-07-24 |
2022-01-27 |
XWPharma Ltd. |
Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative
|
|
CN119970650A
(zh)
|
2020-10-05 |
2025-05-13 |
凯瑞康宁生物工程有限公司 |
γ-羟基丁酸衍生物的修饰释放组合物
|
|
EP4308086B1
(en)
|
2021-03-19 |
2025-10-15 |
XWPharma Ltd. |
Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative
|